Burns Matteson Capital Management LLC Invests $757,000 in Tenet Healthcare Corporation $THC

Burns Matteson Capital Management LLC purchased a new stake in shares of Tenet Healthcare Corporation (NYSE:THC) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 3,810 shares of the company’s stock, valued at approximately $757,000.

Other hedge funds have also recently modified their holdings of the company. NewEdge Advisors LLC boosted its holdings in shares of Tenet Healthcare by 6.1% during the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after purchasing an additional 166 shares during the period. Jones Financial Companies Lllp raised its position in Tenet Healthcare by 299.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after purchasing an additional 1,274 shares during the last quarter. Sivia Capital Partners LLC bought a new stake in shares of Tenet Healthcare in the 2nd quarter worth approximately $290,000. Advisors Asset Management Inc. purchased a new position in shares of Tenet Healthcare during the second quarter valued at approximately $288,000. Finally, Choreo LLC raised its holdings in shares of Tenet Healthcare by 42.5% during the second quarter. Choreo LLC now owns 2,561 shares of the company’s stock valued at $451,000 after acquiring an additional 764 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Insider Buying and Selling at Tenet Healthcare

In other news, EVP Thomas W. Arnst sold 24,000 shares of Tenet Healthcare stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $234.04, for a total value of $5,616,960.00. Following the completion of the transaction, the executive vice president owned 8,012 shares of the company’s stock, valued at $1,875,128.48. The trade was a 74.97% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Paola M. Arbour sold 6,500 shares of the stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the sale, the executive vice president directly owned 29,291 shares in the company, valued at $6,983,853.13. This trade represents a 18.16% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 46,517 shares of company stock worth $10,943,111. 0.81% of the stock is owned by insiders.

Tenet Healthcare Trading Up 0.3%

Shares of NYSE THC opened at $188.56 on Wednesday. Tenet Healthcare Corporation has a 1 year low of $109.82 and a 1 year high of $247.21. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The firm has a 50-day moving average of $213.53 and a 200 day moving average of $205.21. The stock has a market cap of $16.40 billion, a P/E ratio of 12.17, a price-to-earnings-growth ratio of 0.91 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. During the same quarter in the prior year, the company earned $3.44 earnings per share. The business’s revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, sell-side analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Analyst Ratings Changes

THC has been the topic of several recent analyst reports. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a report on Wednesday, March 4th. Royal Bank Of Canada lifted their target price on shares of Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a research note on Thursday, February 12th. Mizuho increased their price target on shares of Tenet Healthcare from $235.00 to $265.00 and gave the stock an “outperform” rating in a research note on Thursday, March 12th. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Sunday, March 1st. Finally, Jefferies Financial Group upped their target price on Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $250.56.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.